Concordare Trials

Concordare Trials uses AI to convert complex clinical study protocols into a standardized digital format, enabling clinical trial sites to streamline their processes and reduce the operational burden imposed by sponsors.

Concordare Trials is active in the digital health space based in New York City, New York.

Within the digital health space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in New York City, New York.

The company is listed at the Techstars company stage of development.

Website: concordaretrials.com